Increasing angiogenesis factors in hypoxic diabetic wounds using siRNA nanotherapeutics
- PMID: 38404503
- PMCID: PMC10884967
- DOI: 10.1016/j.omtn.2024.102142
Increasing angiogenesis factors in hypoxic diabetic wounds using siRNA nanotherapeutics
Similar articles
-
Leveraging Potential of Nanotherapeutics in Management of Diabetic Foot Ulcer.Exp Clin Endocrinol Diabetes. 2022 Oct;130(10):678-686. doi: 10.1055/a-1749-4909. Epub 2022 Mar 3. Exp Clin Endocrinol Diabetes. 2022. PMID: 35240693 Review.
-
45S5 Bioglass® works synergistically with siRNA to downregulate the expression of matrix metalloproteinase-9 in diabetic wounds.Acta Biomater. 2022 Jun;145:372-389. doi: 10.1016/j.actbio.2022.04.010. Epub 2022 Apr 12. Acta Biomater. 2022. PMID: 35421617
-
The emerging potential of siRNA nanotherapeutics in treatment of arthritis.Asian J Pharm Sci. 2023 Sep;18(5):100845. doi: 10.1016/j.ajps.2023.100845. Epub 2023 Sep 16. Asian J Pharm Sci. 2023. PMID: 37881798 Free PMC article. Review.
-
Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape.Int J Mol Sci. 2021 Aug 26;22(17):9216. doi: 10.3390/ijms22179216. Int J Mol Sci. 2021. PMID: 34502144 Free PMC article.
-
Promote anti-inflammatory and angiogenesis using a hyaluronic acid-based hydrogel with miRNA-laden nanoparticles for chronic diabetic wound treatment.Int J Biol Macromol. 2021 Jan 1;166:166-178. doi: 10.1016/j.ijbiomac.2020.10.129. Epub 2020 Oct 22. Int J Biol Macromol. 2021. PMID: 33172616
References
-
- Shaabani E., Sharifiaghdam M., Lammens J., De Keersmaecker H., Vervaet C., De Beer T., Motevaseli E., Ghahremani M.H., Mansouri P., De Smedt S., et al. Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape. Int. J. Mol. Sci. 2021;22:9216. doi: 10.3390/ijms22179216. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources